Novartis Can’t Escape FCA Drug Kickback Suit

Law360, New York (September 5, 2014, 3:52 PM ET) -- A New York federal judge Thursday denied Novartis Pharmaceuticals Corp.’s attempt to escape a whistleblower suit over alleged kickbacks from two of the company’s drugs, letting the government pursue most of its allegations but threatening to reject its pre-Obamacare state Medicaid claims.



District Judge Colleen McMahon ruled that most of the government’s claims against Novartis were sufficiently pled, allowing the U.S. Department of Justice and 11 intervening states to pursue their case against the global pharmaceutical company over claims it submitted to Medicare and some state...

To view the full article, register now.